I get tired for no reason: A single item screening for cancer-related fatigue
I get tired for no reason: A single item screening for cancer-related fatigue
复制标题
DOI：
10.1016/s0885-3924(01)00350-5
复制
发表时间：
2001-11-01
影响因子：
4.7
通讯作者：
Theobald, D
中科院分区：
文献类型：
--
作者：
Kirsh, KL;Passik, S;Theobald, D
本研究考察了标准的效度和敏感性。和特异性的一个单一的项目，以快速筛选病人在门诊肿瘤诊所癌症相关的疲劳。为了扩大Zung抑郁自评量表（Zung Self-Rating Depression Scale，ZSDS）作为其他症状筛查工具的实用性，对单一疲劳项目的实用性进行了研究。疲劳这一项写着“我无缘无故地感到疲劳”，并以“没有或只有一小部分时间”到“大部分或全部时间”的10分制进行评分。52名受试者接受了Zung，癌症治疗贫血功能评估（FACTAn）量表和疲劳症状量表（FSI）。Zung项目与FSI的各个项目高度相关，范围从0.41（p <0.003）到0.71（p <0.0001）。所有10名基于WRDS被认为抑郁的受试者在FA CT-An上也被认为疲劳。将BRDS项目的截止点设置为3级--“大部分时间”--产生了78.95%的敏感性和87.88%的特异性。结果表明，单项法是一种快速、准确的方法。对癌症患者进行疲劳筛查，以触发额外的随访，从而扩大了抑郁症筛查工具对精神疾病以外问题的实用性。J Pain Symptom Manage 2001：22：931-937（C）U.S. Cancer Pain Relief Committee，2001.
This study examined the criterion validity and sensitivity. and specificity of a single item to rapidly screen Patients in ambulatory oncology clinics for cancer-related fatigue. In an effort to expand the utility of the Zung Self-Rating Depression Scale (ZSDS) as a screen for other symptoms, the utility of the single fatigue item wa's examined. The fatigue item reads "I get tired for no reason" and is rated on a Jour-point scale ranging from "none or a little of the time" to "most or all of the time." Fifty-two subjects were administered the Zung, the Functional Assessment of Cancer Therapy-Anemia (FACTAn) scale, and the Fatigue Symptom Inventory (FSI). The Zung item was highly correlated with the ZSDS (r = 0.63, p < 0.0001) and the FACT-An (r = -0.70, p < 0.0001), as well as to the individual items Of the FSI, ranging from 0.41 (p < 0.003) to 0.71 (p < 0.0001). All 10 subjects considered to be depressed based on the ZSDS were also considered to fatigued on the FA CT-An. Setting the ZSDS item cutoff point at level 3-'A good part of the time-yielded a sensitivity of 78.95% and a specificity of 87.88%. It is concluded that a single item can be a fast and accurate way. of screening cancer patients for fatigue to trigger additional follow-up, thus expanding the utility of a depression screening tool for problems other than the pit rely psychiatric. J Pain Symptom Manage 2001:22:931-937 (C) U.S. Cancer Pain Relief Committee, 2001.